212 related articles for article (PubMed ID: 9787136)
1. Secretable human platelet-derived factor V originates from the plasma pool.
Camire RM; Pollak ES; Kaushansky K; Tracy PB
Blood; 1998 Nov; 92(9):3035-41. PubMed ID: 9787136
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor.
Gould WR; Simioni P; Silveira JR; Tormene D; Kalafatis M; Tracy PB
J Thromb Haemost; 2005 Mar; 3(3):450-6. PubMed ID: 15748232
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.
Ayombil F; Abdalla S; Tracy PB; Bouchard BA
J Thromb Haemost; 2013 Aug; 11(8):1532-9. PubMed ID: 23710903
[TBL] [Abstract][Full Text] [Related]
4. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
Thomassen MC; Castoldi E; Tans G; Magdeleyns EJ; Delaunoit C; Debusscher L; Van Assche KJ; Rosing J
Haematologica; 2003 Oct; 88(10):1150-6. PubMed ID: 14555311
[TBL] [Abstract][Full Text] [Related]
5. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
Gould WR; Silveira JR; Tracy PB
J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
[TBL] [Abstract][Full Text] [Related]
6. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C.
Camire RM; Kalafatis M; Simioni P; Girolami A; Tracy PB
Blood; 1998 Apr; 91(8):2818-29. PubMed ID: 9531592
[TBL] [Abstract][Full Text] [Related]
8. Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.
Campbell JE; Meledeo MA; Cap AP
PLoS One; 2014; 9(6):e99181. PubMed ID: 24921658
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
Silveira JR; Kalafatis M; Tracy PB
Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
[TBL] [Abstract][Full Text] [Related]
10. Endocytosis and storage of plasma factor V by human megakaryocytes.
Suehiro Y; Veljkovic DK; Fuller N; Motomura Y; Massé JM; Cramer EM; Hayward CP
Thromb Haemost; 2005 Sep; 94(3):585-92. PubMed ID: 16268476
[TBL] [Abstract][Full Text] [Related]
11. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
12. Plasma factor V activation is prevented by activated protein C in the presence of phospholipid vesicles, not platelets.
Solymoss S; Nguyen KT
Thromb Haemost; 1993 Feb; 69(2):124-9. PubMed ID: 8456424
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
[TBL] [Abstract][Full Text] [Related]
14. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.
Heeb MJ; Kojima Y; Greengard JS; Griffin JH
Blood; 1995 Jun; 85(12):3405-11. PubMed ID: 7780127
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
Aparicio C; Dahlbäck B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
[TBL] [Abstract][Full Text] [Related]
17. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
Cramer TJ; Griffin JH; Gale AJ
Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
[TBL] [Abstract][Full Text] [Related]
18. Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.
Bouchard BA; Chapin J; Brummel-Ziedins KE; Durda P; Key NS; Tracy PB
Blood; 2015 Jun; 125(23):3647-50. PubMed ID: 25896652
[TBL] [Abstract][Full Text] [Related]
19. Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia.
Radu CM; Spiezia L; Bulato C; Gavasso S; Campello E; Sartorello F; Castoldi E; Simioni P
Br J Haematol; 2016 Nov; 175(3):517-524. PubMed ID: 27443583
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
